Learn More
Medchemexpress LLC Flutamide | 13311-84-7 | 99.9% | C11H11F3N2O3 | 500 MG

Supplier: Medchemexpress LLC HYB0022500MG
Flutamide is an Androgen Receptor antagonist with a Ki of 55 nM. It inhibits prostate cancer progression and has shown potential in protecting against hyperthermia-induced multiple organ dysfunction syndrome. The active metabolite, Flutamide-OH, directly binds to the rat anterior pituitary androgen receptor. Flutamide has cytotoxic activity against PC3 and LNCap cells, inducing apoptosis and reducing cell migration and colonization. It downregulates the expression of KLK2 and EMT pathway genes in cells.
- Androgen receptor antagonist
- Inhibits prostate cancer progression
- Protects against hyperthermia-induced multiple organ dysfunction syndrome
- Exhibits cytotoxic activity against PC3 and LNCap cells
- Induces apoptosis and reduces cell migration
- Downregulates KLK2 and EMT pathway genes
- Significantly reduces rat ventral prostate weight in vivo
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.